Capsule endoscopy (CE), introduced in 2000 and FDA-approved in 2001, remains a valuable tool for diagnosing gastrointestinal (GI) lesions, particularly in areas inaccessible to traditional endoscopy. While CE offers non-invasive imaging and improves detection of small bowel diseases and obscure GI bleeding, its widespread use is hindered by limitations such as lack of therapeutic capabilities, inability to obtain biopsies, reliance on peristalsis for movement, and time-consuming image interpretation.
Trending
- Congratulations Dr. Kim on new AAAHC leadership position (AGA)
- When RVUs Go Wrong: Red Flags for Physicians (Medscape)
- GI Side Effects of Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk (GI & Hepatology News)
- Would You Track Your Stools Like You Track Your Steps? (Bloomberg)
- Good news, bad news for gastroenterology (Becker’s GI & Endoscopy)
- Addressing Colonoscopy Burden due to Artificial Intelligence Devices for Polyp Detection (Gastro Journal)
- Gastro Center of Maryland Expands to Bethesda and Silver Spring, Broadening Access to GI Care in the DMV (USA Today)
- To Improve CRC Screening in Patients Aged 45-49, Just Send Them a FIT Kit (GI & Endoscopy News)
